Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manway Liu

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecular Cancer Therapeutics|March 1, 2015
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor EverolimusHung Huynh, Huai-Xiang Hao, Stephen L Chan, et al.
Cancer Cell|July 9, 2014
CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitorsSadhna R Vora, Dejan Juric, Nayoon Kim, et al.
Journal of Proteome Research|January 15, 2024
timsTOF HT Improves Protein Identification and Quantitative Reproducibility for Deep Unbiased Plasma Protein Biomarker DiscoveryDijana Vitko, Wan-Fang Chou, Sara Nouri Golmaei, et al.
Science Translational Medicine|August 2, 2013
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancerMoshe Elkabets, Sadhna Vora, Dejan Juric, et al.
Cancer Cell|April 16, 2015
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomasMoshe Elkabets, Evangelos Pazarentzos, Dejan Juric, et al.
Molecular Cancer Therapeutics|March 11, 2014
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trialsChristine Fritsch, Alan Huang, Christian Chatenay-Rivauday, et al.
NPJ Digital Medicine|December 17, 2019
Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosisTanuja Chitnis, Bonnie I Glanz, Cindy Gonzalez, et al.
Nature|March 31, 2012
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Nature|December 19, 2018
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Nature|May 10, 2019
Next-generation characterization of the Cancer Cell Line EncyclopediaMahmoud Ghandi, Franklin W Huang, Judit Jané-Valbuena, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Cancer Therapeutics|March 1, 2015
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor EverolimusHung Huynh, Huai-Xiang Hao, Stephen L Chan, et al.
Cancer Cell|July 9, 2014
CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitorsSadhna R Vora, Dejan Juric, Nayoon Kim, et al.
Journal of Proteome Research|January 15, 2024
timsTOF HT Improves Protein Identification and Quantitative Reproducibility for Deep Unbiased Plasma Protein Biomarker DiscoveryDijana Vitko, Wan-Fang Chou, Sara Nouri Golmaei, et al.
Science Translational Medicine|August 2, 2013
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancerMoshe Elkabets, Sadhna Vora, Dejan Juric, et al.
Cancer Cell|April 16, 2015
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomasMoshe Elkabets, Evangelos Pazarentzos, Dejan Juric, et al.
Molecular Cancer Therapeutics|March 11, 2014
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trialsChristine Fritsch, Alan Huang, Christian Chatenay-Rivauday, et al.
NPJ Digital Medicine|December 17, 2019
Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosisTanuja Chitnis, Bonnie I Glanz, Cindy Gonzalez, et al.
Nature|March 31, 2012
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Nature|December 19, 2018
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Nature|May 10, 2019
Next-generation characterization of the Cancer Cell Line EncyclopediaMahmoud Ghandi, Franklin W Huang, Judit Jané-Valbuena, et al.
Pageof 2